AR030018A1 - DERIVATIVES OF BENZO (D) (1,3) OXAZIN-2-ONA, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM AND THE USE OF THE SAME TO PREPARE MEDICATIONS AS PROGESTERONE RECEPTING MODULATORS - Google Patents

DERIVATIVES OF BENZO (D) (1,3) OXAZIN-2-ONA, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM AND THE USE OF THE SAME TO PREPARE MEDICATIONS AS PROGESTERONE RECEPTING MODULATORS

Info

Publication number
AR030018A1
AR030018A1 ARP000102155A ARP000102155A AR030018A1 AR 030018 A1 AR030018 A1 AR 030018A1 AR P000102155 A ARP000102155 A AR P000102155A AR P000102155 A ARP000102155 A AR P000102155A AR 030018 A1 AR030018 A1 AR 030018A1
Authority
AR
Argentina
Prior art keywords
oxazin
benzo
pharmaceutical compositions
recepting
ona
Prior art date
Application number
ARP000102155A
Other languages
Spanish (es)
Original Assignee
Wyeth Corp
Ligand Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp, Ligand Pharm Inc filed Critical Wyeth Corp
Publication of AR030018A1 publication Critical patent/AR030018A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un derivado benzo[d][1,3]oxazin-2-ona o una sal farmacéuticamente aceptable de la misma de formula general (1) en donde R1, R2, R3, R4 y R5 tiene el significado dado en la memoria descriptiva, composiciones farmacéuticas que las contienen y el uso de los mismos para preparar un medicamento para inducir la contracepcion, terapia de reemplazo hormonal, fibroides miometrial uterina, endometriosis, hipertrofia prostática benigna; carcinomas y adenocarcinomas del endometrio, ovario, pecho, colon, prostata, pituitaria, meningioma y para sincronizar el estro de un mamífero.A benzo [d] [1,3] oxazin-2-one derivative or a pharmaceutically acceptable salt thereof of general formula (1) wherein R1, R2, R3, R4 and R5 has the meaning given in the specification, pharmaceutical compositions containing them and the use thereof to prepare a medicament for inducing contraception, hormone replacement therapy, uterine myometrial fibroids, endometriosis, benign prostatic hypertrophy; carcinomas and adenocarcinomas of the endometrium, ovary, chest, colon, prostate, pituitary, meningioma and to synchronize the estrus of a mammal.

ARP000102155A 1999-05-04 2000-05-04 DERIVATIVES OF BENZO (D) (1,3) OXAZIN-2-ONA, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM AND THE USE OF THE SAME TO PREPARE MEDICATIONS AS PROGESTERONE RECEPTING MODULATORS AR030018A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30454999A 1999-05-04 1999-05-04

Publications (1)

Publication Number Publication Date
AR030018A1 true AR030018A1 (en) 2003-08-13

Family

ID=37515806

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000102155A AR030018A1 (en) 1999-05-04 2000-05-04 DERIVATIVES OF BENZO (D) (1,3) OXAZIN-2-ONA, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM AND THE USE OF THE SAME TO PREPARE MEDICATIONS AS PROGESTERONE RECEPTING MODULATORS

Country Status (1)

Country Link
AR (1) AR030018A1 (en)

Similar Documents

Publication Publication Date Title
ECSP055576A (en) USE OF CYCLOTIOCARBAMATE DERIVATIVES IN THE TREATMENT OF CONDITIONS RELATED TO HORMONES
ES2233998T3 (en) COMPOUNDS THAT INCLUDE A SULFAMATE GROUP.
HUP0300335A2 (en) 8-betha-hydrocarbyl-substituted estratrienes as selective estrogens, their use and pharmaceutical compositions containing them
RU2007101304A (en) PROGESTERON RECEPTOR MODULAR CONTAINING PYRROL-OXINDOL DERIVATIVES AND APPLICATION
US20050085470A1 (en) 6-Amino-1,4-dihydro-benzo[d][1,3] oxazin-2-ones and analogs useful as progesterone receptor modulators
AR027059A1 (en) BASES OF INDOLIC MANNICH, PROCEDURE FOR THE PREPARATION, MEDICATIONS CONTAINING THESE COMPOUNDS AND THEIR USE FOR THE PREPARATION OF MEDICINES
PE20040157A1 (en) NON-STEROID PROGESTINES
WO2007016385A3 (en) Use of substituted 5-amino-1h-pyrrole-2-carbonitrile derivatives as progesterone receptor modulators
HUP9902121A2 (en) Indole derivatives as antagonists of gonadotropin releasing hormone and pharmaceutical compositions containing them
CR10289A (en) "STRATRIENS 9-ALFA-SUBSTITUTED AS SELECTIVE EFFECTIVENESS STROGENS" (DIVISIONAL)
ES2108240T3 (en) DERIVATIVES OF THOSEMICARBAZONE OF 2-FORMILPIRIDINA, ITS PREPARATION AND ITS USE AS ANTI-TUMOR AGENTS.
AR034392A1 (en) COMPOUNDS DERIVED FROM 3, 16-DIHIDROXI-ESTRA-1,3,5 (10) -TRIENO, EMPLOYMENT OF THE SAME AND STRUCTURAL PARTS OF THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BR0113165A (en) 4-Pyrimidinamine derivatives, pharmaceutical compositions and related methods
AR030018A1 (en) DERIVATIVES OF BENZO (D) (1,3) OXAZIN-2-ONA, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM AND THE USE OF THE SAME TO PREPARE MEDICATIONS AS PROGESTERONE RECEPTING MODULATORS
AR029632A1 (en) INDOL-2-ONA DERIVATIVES, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM AND THE USE OF SUCH DERIVATIVES FOR THE PREPARATION OF MEDICINES
PE20020804A1 (en) USE OF GESTAGENS TO INHIBIT ACCELERATED MATURATION OF THE ENDOMETRIUM DURING INFERTILITY TREATMENT
ATE275973T1 (en) CONTRACEPTIVE COMPOSITIONS CONTAINING PROGESTENES AND PROGESTERONE ANTAGONISTS
UY26665A1 (en) STRATRIANS SUBSTITUTED AS SELECTIVELY ACTIVE ESTHROGENS
PA8450901A1 (en) Erythromycin derivatives
UY29861A1 (en) USE OF ESTRADIOL VALERATE IN COMBINATION WITH DIENOGEST FOR ORAL THERAPY OF THE UNITED DYSFUNCTIONAL UTERINE HEMORRAGY WITH AN ORAL ANTICONCEPTION
ECSP109872A (en) STRATRIENS 8-BETA-SUBSTITUTED AS SELECTIVE ACTION STRATEGES
AR029630A1 (en) A COMPOSITE DERIVED FROM BENZOXAZINE, PHARMACEUTICAL COMPOSITION CONTAINING IT AND THE USE OF THE SAME FOR THE PREPARATION OF A MEDICINAL PRODUCT
AR039228A1 (en) HORMONAL REPLACEMENT THERAPY
BR0112791A (en) 16alpha-substituted steroidal compound, use thereof, treatment methods for selective activation of alpha subtype estrogen receptors, and for hormone replacement therapy or contraception, and, pharmaceutical composition
AR039227A1 (en) HORMONAL REPLACEMENT THERAPY

Legal Events

Date Code Title Description
FA Abandonment or withdrawal